Xarelto Lawsuit Claims Blood Thinner Was Fraudulently Marketed By Manufacturers

BloodThinnerHelp.com reports on a lawsuit filed against pharmaceutical manufacturers Janssen Pharmaceuticals (a subdivision of Johnson & Johnson) and Bayer AG which alleges that the companies have fraudulently misrepresented the risks and benefits of anticoagulant Xarelto. This particular complaint includes 32 counts and was filed under number 15-L-581 in the St. Clair County Circuit Court on October 13th of 2015.

The lawsuit alleges that these manufacturers also failed to properly warn doctors about the dangers surrounding their blood-thinner, specifically due to its lack of antidote. The plaintiff states that the drug was advertised and marketed as if its benefits far outweighed any risks, however, he has now concluded that this is not the case. He seeks damages in excess of $50,000 as well as money to cover the cost of his legal pursuit.

Xarelto lawsuits alleging much of the same have skyrocketed in number recently. In federal court, there are nearly 2,000 lawsuits filed against manufacturers of Xarelto. Due to their similar allegations, which state that Xarelto use puts patients at increased risk for dangerous uncontrollable bleeding episodes, the cases have been consolidated to form multidistrict litigation number 2592, and are being overseen by the Honorable Judge Eldon Fallon in the Eastern District of Louisiana.

The cases were consolidated by the U.S. Judicial Panel on Multidistrict Litigation. This is done if the cases are incredibly similar in order to avoid different rulings by multiple judges and duplicate discovery. It also helps to conserve the time and expense of litigation for those involved, and is seen as a sort of “fast-tracking” of initial legal proceedings.

Many plaintiffs in the consolidated lawsuits frequently discuss Xarelto’s lack of antidote, which is still the case after 4 years on the market. Because Xarelto has no antidote, if someone taking it suffers even minor injuries and begins to bleed, things can get extremely dangerous very quickly. In these circumstances, physicians will be unable to get the patient’s blood to clot, and will therefore have to resort to extreme, life-saving measures such as surgery and blood transfusions.

For those patients taking a traditional blood thinner, such as Warfarin, the story is a very different one. If these people become injured and bleed, physicians have an available antidote in vitamin K. If they treat the bleeding patient with vitamin K, it will counter the effects of the drug and allow that person’s blood to clot. This antidote can be a lifesaving difference, and many plaintiffs say that manufacturers who decided to market Xarelto without one were showing complete negligence.

Cases involved in the current MDL are expected to grow in number as they await further trial preparations. Attorney Joseph Osborne is working to help ensure that everyone who has been negatively affected by Xarelto will have the opportunity to explore their legal rights. He is offering free legal consultations to anyone who used Xarelto and then suffered an adverse health event that they attribute to the drug. These individuals may be entitled to compensation.

For additional information on the mounting Xarelto lawsuits, or to ask questions, please contact Joseph Osborne, Esq. by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park 433 Plaza Real Blvd., Ste. 271 Boca Raton, FL 33432

FacebookTwitterGoogleDiggRedditLinkedIn

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.